Aubagio: A Second Oral Drug for MS

FDA approved picture of pills

Rocky Mountain MS Center shares this Breaking News The U.S. Food and Drug Administration has approved a new, once-daily, medication for the treatment of relapsing forms of multiple sclerosis. Aubagio (teriflunomide), made by Genzyme, a Sanofi company, is expected to be available for prescription in the US by October 1, …

Continue reading